Dr. David Palma, MD, PhD
@drdavidpalma.bsky.social
📤 302
📥 49
📝 5
Friendly reminder that the deadline for the Red Journal SBRT special issue is June 30. It's going to be a great issue, with more than 100 submissions already!
3 months ago
0
2
0
Hey
#radoncs
! Quadshot News is looking for financial support to continue their outstanding work. They are one of my go-to avenues to keep up in the oncology world. I get a short email every day that highlights a few key papers. Consider a donation to keep them up and running:
quadshotnews.com
loading . . .
QuadShot – News
https://quadshotnews.com/
4 months ago
1
0
0
Interested in delivering palliative radiation using diagnostic CTs rather than a CT simulation? See below for a discussion of some of the data.
add a skeleton here at some point
8 months ago
0
5
1
Hey Rad Onc community! The Red Journal
@ijrobp.bsky.social
is calling for papers for a new special issue: SBRT - From Clinical Trials to Your Clinic Details below...⬇️⬇️⬇️
8 months ago
1
9
5
reposted by
Dr. David Palma, MD, PhD
Matthias Guckenberger
9 months ago
Todas is HCC day! - RTOG 1112 - HCC unsuitable for or refractory to local-regional Tx (n=177) - SBRT & Sorafenib vs Sorafenib - After adjustment for stratification factors, improved OS after SBRT (HR 0.72) - Median PFS improved from 5.5 to 9.2 mo (HR 0.55)
jamanetwork.com/journals/jam...
loading . . .
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
This phase 3 randomized clinical trial evaluates whether stereotactic body radiation therapy improves outcomes in patients with locally advanced hepatocellular carcinoma compared with sorafenib alone.
https://jamanetwork.com/journals/jamaoncology/article-abstract/2827892
0
3
2
reposted by
Dr. David Palma, MD, PhD
Matthias Guckenberger
9 months ago
Safe practice of spine SBRT requires high-quality data about SC dose tolerance - Cohort study 2051 pts - 30 cases of RM, 19 of which G3 to G4 - 2a rate of G1-4 RM 1.8% - cord dose D0.1cc of 19.1Gy / Dmax of 20.8Gy = 1.0% risk of G3 to G4 RM at 2 years
jamanetwork.com/journals/jam...
loading . . .
Radiation Myelitis After Hypofractionated Spine Stereotactic Body Radiation Therapy
This cohort study characterizes the risk of radiation myelitis after spine stereotactic body radiation therapy to update the current dosimetric constraints.
https://jamanetwork.com/journals/jamaoncology/article-abstract/2827893
0
6
2
you reached the end!!
feeds!
log in